1. Gaver DP 3rd, Nieman GF, Gatto LA, Cereda M, Habashi NM, Bates JHT. The POOR get POORer: a hypothesis for the pathogenesis of ventilator-induced lung injury. Am J Respir Crit Care Med. 2020;202(8):1081-1087. doi:10.1164/rccm.202002-0453CP
2. Fernando SM, Tran A, Cheng W, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive Care Med. 2020;46(6):1170-1179. doi:10.1007/s00134-020-06036-z
3. Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2022;43(6):687-713. doi:10.1017/ice.2022. 88
4. Zilberberg MD, Nathanson BH, Puzniak LA, Shorr AF. descriptive epidemiology and outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012-2019. Crit Care Med. 2022;50(3): 460-468. doi:10.1097/CCM.0000000000005298
5. Ranzani OT, Niederman MS, Torres A. Ventilator-associated pneumonia. Intensive Care Med. 2022;48(9):1222-1226. doi:10.1007/s00134-022-06773-3
6. Wu D, Wu C, Zhang S, Zhong Y. Risk factors of ventilator-associated pneumonia in critically III patients. Front Pharmacol. 2019;10:482. doi: 10.3389/fphar.2019.00482
7. Álvarez-Lerma F, Palomar-Martínez M, Sánchez-García M, et al. Prevention of ventilator-associated pneumonia: the multimodal approach of the Spanish ICU “pneumonia zero” program. Crit Care Med. 2018;46(2):181-188. doi:10.1097/CCM.0000000000002736
8. Mastrogianni M, Katsoulas T, Galanis P, Korompeli A, Myrianthefs P. The impact of care bundles on ventilator-associated pneumonia (VAP) prevention in adult ICUs: a systematic review. Antibiotics (Basel). 2023; 12(2):227. doi:10.3390/antibiotics12020227
9. Vieira PC, de Oliveira RB, da Silva Mendonça TM. Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles? Med Intensiva (Engl Ed). 2022;46(5):259-268. doi:10.1016/j.medine.2020.09.010
10. Frondelius T, Atkova I, Miettunen J, Rello J, Jansson MM. Diagnostic and prognostic prediction models in ventilator-associated pneumonia: systematic review and meta-analysis of prediction modelling studies. J Crit Care. 2022;67:44-56. doi:10.1016/j.jcrc.2021.10.001
11. Branco A, Lourençone EMS, Monteiro AB, Fonseca JP, Blatt CR, Caregnato RCA. Education to prevent ventilator-associated pneumonia in intensive care unit. Rev Bras Enferm. 2020;73(6):e20190477. doi:10. 1590/0034-7167-2019-0477
12. Howes D, Gray SH, Brooks SC, et al. Canadian Guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: a joint statement from The Canadian Critical Care Society (CCCS), Canadian Neurocritical Care Society (CNCCS), and the Canadian Critical Care Trials Group (CCCTG). Resuscitation. 2016; 98:48-63. doi:10.1016/j.resuscitation.2015.07.052
13. Dela Cruz CS, Evans SE, Restrepo MI, et al. Understanding the host in the management of pneumonia. an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2021;18(7):1087-1097. doi:10.1513/AnnalsATS.202102-209ST
14. Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021;73(5):e1029-e1044. doi:10.1093/cid/ciab549
15. Abdul-Aziz MH, Alffenaar JC, Bassetti M, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46(6):1127-1153. doi:10.1007/s00134-020-06050-1
16. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731. doi:10.1093/eurheartj/ehac237
17. Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European Society of Intensive Care Medicine). Clin Microbiol Infect. 2022;28(4):521-547. doi:10.1016/j.cmi.2021.11.025
18. Robba C, Poole D, McNett M, et al. Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus. Intensive Care Med. 2020;46(12): 2397-2410. doi:10.1007/s00134-020-06283-0
19. Mogyoródi B, Skultéti D, Mezocsáti M, et al. Effect of an educational intervention on compliance with care bundle items to prevent ventilator-associated pneumonia. Intensive Crit Care Nurs. 2023;75:103342. doi:10. 1016/j.iccn.2022.103342
20. Viana WN, Bragazzi C, Couto de Castro JE, Alves MB, Rocco JR. Ventilator-associated pneumonia prevention by education and two combined bedside strategies. Int J Qual Health Care. 2013;25(3):308-313. doi:10.1093/intqhc/mzt025
21. Aloush SM. Does educating nurses with ventilator-associated pneumonia prevention guidelines improve their compliance? Am J Infect Control. 2017;45(9):969-973. doi:10.1016/j.ajic.2017.04.009
22. Kalyan G, Bibi R, Kaur R, et al. Knowledge and practices of intensive care unit nurses related to prevention of ventilator associated pneumonia in selected intensive care units of a tertiary care centre, India. Iran J Nurs Midwifery Res. 2020;25(5):369-375. doi:10.4103/ijnmr.IJNMR_128_18
23. Abad CL, Formalejo CP, Mantaring DML. Assessment of knowledge and implementation practices of the ventilator acquired pneumonia (VAP) bundle in the intensive care unit of a private hospital. Antimicrob Resist Infect Control. 2021;10(1):161. doi:10.1186/s13756-021-01027-1
24. Mishra R, Rani N. Effectiveness of structured teaching program on knowledge and practice regarding care bundle on prevention of ventilator-associated pneumonia among nurses. Int Arch Nurs Health Care. 2020;6:149. doi:10.23937/2469-5823/1510149
</ol>
<p>